For: | Trakarnsanga A, Ithimakin S, Weiser MR. Treatment of locally advanced rectal cancer: Controversies and questions. World J Gastroenterol 2012; 18(39): 5521-5532 [PMID: 23112544 DOI: 10.3748/wjg.v18.i39.5521] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i39/5521.htm |
Number | Citing Articles |
1 |
Shereen El Shorbagy, Ola M. Elfarargy, Reham A. Salem, Amina M. Elnaggar, Ola A. Harb, Abeer M. Abdelbary, Hassan R. Ashour, Loay M. Gertallah. Peripheral and Tissue Lymphocytes as Predictors of Pathological Response in Locally Advanced Rectal Cancer Post Neoadjuvant Chemoradiotherapy. Journal of Cancer Therapy 2017; 8(03): 250 doi: 10.4236/jct.2017.83021
|
2 |
Ben Huang, Shaobo Mo, Liang Zhu, Tianhong Xu, Guoxiang Cai. The survival and clinicopathological differences between patients with stage IIIA and stage II rectal cancer: An analysis of 12,036 patients in the SEER database. Oncotarget 2016; 7(48): 79787 doi: 10.18632/oncotarget.12970
|
3 |
HAN JO KIM, SANG BYUNG BAE, DONGJUN JEONG, EUN SEOG KIM, CHANG-NAM KIM, DONG-GUK PARK, TAE SUNG AHN, SUNG WOO CHO, EUNG JIN SHIN, MOON SOO LEE, MOO JUN BAEK. Upregulation of stromal cell-derived factor 1α expression is associated with the resistance to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: Angiogenic markers of neoadjuvant chemoradiation. Oncology Reports 2014; 32(6): 2493 doi: 10.3892/or.2014.3504
|
4 |
A. P. Zbar. Commentary on neoadjuvant therapy followed by local excision and two-stage total mesorectal excision: a new strategy for sphincter preservation in locally advanced ultra-low rectal cancer. Gastroenterology Report 2014; 2(2): 134 doi: 10.1093/gastro/gou024
|
5 |
Daniel W. Nelson, Anton J. Bilchik. Clinical Decision Making in Colorectal Surgery. 2020; : 341 doi: 10.1007/978-3-319-65942-8_44
|
6 |
Roberto Bini, Simone Comelli, Alfredo Addeo, Tiziana Viora, Federica Vana, Giacomo Paolo Vaudano, Daniele Savio, Renzo Leli. Inferior Mesenteric Artery Chemoembolization and Chemotherapy for Advanced Rectal Cancer: Report of a Clinical Case. Tumori Journal 2015; 101(3): e82 doi: 10.5301/tj.5000270
|
7 |
Jan Grosek, Vaneja Velenik, Ibrahim Edhemovic, Mirko Omejc. The influence of the distal resection margin length on local recurrence and long- term survival in patients with rectal cancer after chemoradiotherapy and sphincter- preserving rectal resection. Radiology and Oncology 2017; 51(2): 169 doi: 10.1515/raon-2016-0030
|
8 |
Matthias Zitt, Alexander DeVries, Josef Thaler, Reinhold Kafka-Ritsch, Wolfgang Eisterer, Peter Lukas, Dietmar Öfner. Long-term surveillance of locally advanced rectal cancer patients with neoadjuvant chemoradiation and aggressive surgical treatment of recurrent disease: a consecutive single-centre experience. International Journal of Colorectal Disease 2015; 30(12): 1705 doi: 10.1007/s00384-015-2366-8
|
9 |
Siddhartha Nanda, Jacob T. Antunes, Amrish Selvam, Kaustav Bera, Justin T. Brady, Jayakrishna Gollamudi, Kenneth Friedman, Joseph E. Willis, Conor P. Delaney, Raj M. Paspulati, Anant Madabhushi, Satish Viswanath, Baowei Fei, Cristian A. Linte. Integrating radiomic features from T2-weighted and contrast-enhanced MRI to evaluate pathologic rectal tumor regression after chemoradiation. Medical Imaging 2019: Image-Guided Procedures, Robotic Interventions, and Modeling 2019; : 100 doi: 10.1117/12.2513945
|
10 |
Adan Z. Becerra, Steven D. Wexner, David W. Dietz, Zhaomin Xu, Christopher T. Aquina, Carla F. Justiniano, Alex A. Swanger, Larissa K. Temple, Katia Noyes, John R. Monson, Fergal J. Fleming. Nationwide Heterogeneity in Hospital-Specific Probabilities of Rectal Cancer Understaging and Its Effects on Outcomes. Annals of Surgical Oncology 2018; 25(8): 2332 doi: 10.1245/s10434-018-6530-6
|
11 |
Mehmet Artaç, Bassel F. El-Rayes, Suayib Yalcin, Philip A. Philip. Textbook of Gastrointestinal Oncology. 2019; : 161 doi: 10.1007/978-3-030-18890-0_9
|
12 |
Wai‐Hun Cheah. Pictorial essay on MRI local staging of rectal carcinoma: An easy approach. Asia-Pacific Journal of Clinical Oncology 2023; 19(2) doi: 10.1111/ajco.13782
|
13 |
Mehmet Artac, Levent Korkmaz, Bassel El-Rayes, Philip A. Philip. An update on the multimodality of localized rectal cancer. Critical Reviews in Oncology/Hematology 2016; 108: 23 doi: 10.1016/j.critrevonc.2016.10.004
|
14 |
Kuo-Piao Chung, Li-Ju Chen, Yao-Jen Chang, Yun-Jau Chang. Can composite performance measures predict survival of patients with colorectal cancer?. World Journal of Gastroenterology 2014; 20(42): 15805-15814 doi: 10.3748/wjg.v20.i42.15805
|
15 |
Mirko Omejc, Maja Potisek. Prognostic significance of tumor regression in locally advanced rectal cancer after preoperative radiochemotherapy. Radiology and Oncology 2017; 52(1): 30 doi: 10.1515/raon-2017-0059
|
16 |
Elisa Pezzolo, Yasmina Modena, Barbara Corso, Pietro Giusti, Milena Gusella. Germ line polymorphisms as predictive markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: a 5-year literature update and critical review. European Journal of Clinical Pharmacology 2015; 71(5): 529 doi: 10.1007/s00228-015-1824-0
|
17 |
Natalia Krasteva, Dessislava Staneva, Bela Vasileva, George Miloshev, Milena Georgieva. Bioactivity of PEGylated Graphene Oxide Nanoparticles Combined with Near-Infrared Laser Irradiation Studied in Colorectal Carcinoma Cells. Nanomaterials 2021; 11(11): 3061 doi: 10.3390/nano11113061
|
18 |
Taylor P. Uccello, Maggie L. Lesch, Sarah A. Kintzel, Lauren B. Gradzewicz, Lillia Lamrous, Shawn P. Murphy, Fergal J. Fleming, Bradley N. Mills, Joseph D. Murphy, Angela Hughson, Gary Hannon, Jesse Garrett-Larsen, Haoming Qiu, Michael G. Drage, Jian Ye, Nicholas W. Gavras, David C. Keeley, Tanzy M. T. Love, Elizabeth A. Repasky, Edith M. Lord, David C. Linehan, Scott A. Gerber. New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy. Cell Death & Disease 2023; 14(7) doi: 10.1038/s41419-023-05999-3
|
19 |
Gabriele Bellio, Marina Troian, Arianna Pasquali, Nicolò de Manzini. Outcomes of laparoscopic surgery for pT3/pT4 colorectal cancer in young vs. old patients. Minerva Chirurgica 2019; 74(4) doi: 10.23736/S0026-4733.19.07895-7
|
20 |
Edoardo D’Angelo, Carlo Zanon, Francesca Sensi, Maura Digito, Massimo Rugge, Matteo Fassan, Marco Scarpa, Salvatore Pucciarelli, Donato Nitti, Marco Agostini. miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma. Journal of Clinical Pathology 2018; 71(4): 344 doi: 10.1136/jclinpath-2017-204690
|
21 |
Vincent Ho, Liping Chung, Maxine Revoltar, Stephanie H. Lim, Thein-Ga Tut, Askar Abubakar, Chris J. Henderson, Wei Chua, Weng Ng, Mark Lee, Paul De Souza, Matthew Morgan, C. Soon Lee, Joo-Shik Shin, Shian-Ying Sung. MRE11 and ATM Expression Levels Predict Rectal Cancer Survival and Their Association with Radiotherapy Response. PLOS ONE 2016; 11(12): e0167675 doi: 10.1371/journal.pone.0167675
|
22 |
Xiang-cai Zou, Qi-wen Wang, Ji-min Zhang. Comparison of 5–FU-based and Capecitabine-based Neoadjuvant Chemoradiotherapy in Patients With Rectal Cancer: A Meta-analysis. Clinical Colorectal Cancer 2017; 16(3): e123 doi: 10.1016/j.clcc.2017.01.009
|
23 |
Michael C. Yim, Zhouping Wei, Jacob T. Antunes, Neil K. R. Sehgal, Kaustav Bera, Justin T. Brady, Kenneth Friedman, Joseph E. Willis, Andrei Purysko, Raj M. Paspulati, Anant Madabhushi, Satish Viswanath, Baowei Fei, Cristian A. Linte. Radiomic characterization of perirectal fat on MRI enables accurate assessment of tumor regression and lymph node metastasis in rectal cancers after chemoradiation. Medical Imaging 2019: Image-Guided Procedures, Robotic Interventions, and Modeling 2019; : 82 doi: 10.1117/12.2512612
|
24 |
Dong Won Baek, Gyeonghwa Kim, Byung Woog Kang, Hye Jin Kim, Su Yeon Park, Jun Seok Park, Gyu-Seog Choi, Min Kyu Kang, Keun Hur, Jong Gwang Kim. High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer. Journal of Cancer Research and Clinical Oncology 2020; 146(1): 105 doi: 10.1007/s00432-019-03099-4
|
25 |
Gayathri Anandappa, Ian Chau. Evolving Tissue and Circulating Biomarkers as Prognostic and Predictive Tools in Colorectal Cancer. Current Colorectal Cancer Reports 2018; 14(5): 138 doi: 10.1007/s11888-018-0410-0
|
26 |
Gavin G. Calpin, Matthew G. Davey, Barry Maguire, Stefan Morarasu, Noel E. Donlon, Kevin C. Cahill, John O. Larkin. Optimal approaches to flap reconstruction following abdominoperineal resection: A systematic review. The Surgeon 2025; doi: 10.1016/j.surge.2025.01.010
|
27 |
Qiuji Wu, Awatef Allouch, Audrey Paoletti, Celine Leteur, Celine Mirjolet, Isabelle Martins, Laurent Voisin, Frédéric Law, Haithem Dakhli, Elodie Mintet, Maxime Thoreau, Zeinaf Muradova, Mélanie Gauthier, Olivier Caron, Fabien Milliat, David M Ojcius, Filippo Rosselli, Eric Solary, Nazanine Modjtahedi, Eric Deutsch, Jean-Luc Perfettini. NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy. Cell Death & Differentiation 2017; 24(9): 1632 doi: 10.1038/cdd.2017.91
|
28 |
Chun-Yi Liang, Mao-Dong Chen, Xi-Xi Zhao, Cheng-Gong Yan, Ying-Jie Mei, Yi-Kai Xu. Multiple mathematical models of diffusion-weighted magnetic resonance imaging combined with prognostic factors for assessing the response to neoadjuvant chemotherapy and radiation therapy in locally advanced rectal cancer. European Journal of Radiology 2019; 110: 249 doi: 10.1016/j.ejrad.2018.12.005
|
29 |
Shuncong Wang, Yewei Liu, Yuanbo Feng, Jian Zhang, Johan Swinnen, Yue Li, Yicheng Ni. A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed. Cancers 2019; 11(11): 1782 doi: 10.3390/cancers11111782
|
30 |
|